MHS: To Present At Thomas Weisel Healthcare Conference @ 14:05 ET [delayed] -
MHS touches 200-day moving average at 48.37 -
www.companiesandmarkets.com: Medco Health Solutions - Competitive Intelligence -
FDA tests 'personalized medicine' -
Medco Health Solutions and FDA form research partnership -
Medco, FDA To Begin Two-Year Partnership To Study Market For Genetic Testing -
Medco Announces Research Collaboration with FDA Focused on Personalized Medicine -
MHS: To Present At BMO Focus on Healthcare Conference @ 09:00 ET [delayed] -
Medco CEO to Present at BMO Capital Markets Conference -
Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference -
Medco Health Solutions Q2 profit up on new client wins, lifts FY08 EPS forecast - Update -
Medco Health Solutions (MHS) NewsBite - MHS Profit Rises on Higher Drug Prices -
Medco Health Solutions Raises Guidance, but Remains Inline with Estimates -
MEDCO HEALTH SOLUTIONS INC SEES FY 2008 SHR $2.30 TO $2.33 EXCLUDING ITEMS -
MEDCO HEALTH SOLUTIONS INC REUTERS ESTIMATES Q2 SHR VIEW $0.54, -
MEDCO HEALTH SOLUTIONS INC Q2 SHR $0.56 -
MEDCO HEALTH SOLUTIONS INC Q2 REVENUE ROSE 15.6 PCT TO $12.8 BLN -
Medco Health Solutions (MHS) NewsBite - MHS Down on Inflation Data -
Medco Health Solutions Inc. (MHS) Corporate Event Announcement Notice -